中國制藥企業的產品組合研究
University of Macau === Institute of Chinese Medical Sciences
| Main Author: | |
|---|---|
| Language: | Chinese |
| Published: |
University of Macau
2010
|
| Subjects: | |
| Online Access: | http://umaclib3.umac.mo/record=b2454939 |
| id |
ndltd-MACAU-oai-libdigital.umac.mo-b2454939 |
|---|---|
| record_format |
oai_dc |
| spelling |
ndltd-MACAU-oai-libdigital.umac.mo-b24549392013-01-07T23:06:25Z2010http://umaclib3.umac.mo/record=b2454939UM_THESESUniversity of MacauInstitute of Chinese Medical SciencesUniversity of MacauMedicinal Administration -- Institute of Chinese Medical SciencesPharmaceutical industry -- China藥業 -- 中國chi馮雪敏中國制藥企業的產品組合研究Study on the product portfolio of pharmaceutical companies in ChinaWith the influence of drug patents expired, pharmaceutical R&D capacity decreased and the global financial crisis, pharmaceutical R&D and market encountered an unprecedented impact. But a number of multinational pharmaceutical companies who rely on a strong product portfolio structure can remain deeply entrenched in the ranking position. In contrast, the Chinese pharmaceutical industries are more weak in the sustainable development of the capacity of product portfilo model. How to find an effective product portfolio management, and establish product portfolio combining the innovative drug with the advantage products in the market is a necessary strategy for the enterprise to maintain long-term growth capacity. In this paper, we choose the Chinese pharmaceutical enterprises as the object, product portfolio management as the core, brand management and patent management as the two wings, to research Chinese pharmaceutical portfolio management model. After stating the research questions, we research the portfolio management experiences from the three largest global pharmaceutical mergers and acquisitions. Then, through the literature review of product portfolio, we find that previous studies have cut the overall product management, we should combine the brand management and patent management with product portfolio management to establish a perfect product portfolio model under the reality of Chinese pharmaceutical industry. In case study, Harbin Pharmacology Group, Yangtze River Pharmaceutical Group and Hengrui Medicine were selected for the example. Through three aspects of portfolio management, brand management, and patent management to study Chinese pharmaceutical enterprises portfolio management, the link among portfolio management, brand management and patent management can be got by comparison and analysis. Finally, conclusions and policy recommendations are given out on the Chinese pharmaceutical industry portfolio model, brand management and patent management: Chinese pharmaceutical enterprises must to break through the low level and replication patterns, find reasonable product portfolio and optimize product portfolio; While economic integration, strengthen the technical relevance of portfolio optimization; establish a consistent brand portfolio management and patent management system, strengthen the mutual support of product portfolio, brand management and patent management capacity; Different product portfolio in different patent management, construce patent defense system; Change the direction of product structure and develop areas, and gradually transate to proprietary companies; Be in actively seeking mergers and acquisitions, integration of resources and proper diversification. |
| collection |
NDLTD |
| language |
Chinese |
| sources |
NDLTD |
| topic |
Medicinal Administration -- Institute of Chinese Medical Sciences Pharmaceutical industry -- China 藥業 -- 中國 |
| spellingShingle |
Medicinal Administration -- Institute of Chinese Medical Sciences Pharmaceutical industry -- China 藥業 -- 中國 馮雪敏 中國制藥企業的產品組合研究 |
| description |
University of Macau === Institute of Chinese Medical Sciences |
| author |
馮雪敏 |
| author_facet |
馮雪敏 |
| author_sort |
馮雪敏 |
| title |
中國制藥企業的產品組合研究 |
| title_short |
中國制藥企業的產品組合研究 |
| title_full |
中國制藥企業的產品組合研究 |
| title_fullStr |
中國制藥企業的產品組合研究 |
| title_full_unstemmed |
中國制藥企業的產品組合研究 |
| title_sort |
中國制藥企業的產品組合研究 |
| publisher |
University of Macau |
| publishDate |
2010 |
| url |
http://umaclib3.umac.mo/record=b2454939 |
| work_keys_str_mv |
AT féngxuěmǐn zhōngguózhìyàoqǐyèdechǎnpǐnzǔhéyánjiū AT féngxuěmǐn studyontheproductportfolioofpharmaceuticalcompaniesinchina |
| _version_ |
1716479091825180672 |